National Healthcare Security Administration

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

Retrieved on: 
Wednesday, December 13, 2023
Marketing, Shanghai Stock Exchange, Quality of life, Epilepsy, A&B, Peptide, Absorption, National Healthcare, Methotrexate, National Healthcare Security Administration, Insurance, Safety, Tetrabenazine, Heart failure, CMS, Protein, Light, Recombinant, Acute decompensated heart failure, Sun Pharma, Nasal mucosa, PASI, Tablet, Patient, Psoriasis, Chemokine, Diazepam, Huntington's disease, Sale, Social Security, Tildrakizumab, Social, Vitamin E

China Medical System actively responds to national policies to promote innovative products to be included in the NRDL.

Key Points: 
  • China Medical System actively responds to national policies to promote innovative products to be included in the NRDL.
  • In addition, innovative drug Methotrexate Injection (Metoject) indicated for psoriasis approved in March 2023 has been included in category A of the National Reimbursement Drug List.
  • It is the first nasal spray formulation of diazepam in China and the first drug approved in China for the treatment of seizure clusters.
  • CMS actively responds to national policies to promote innovative products to be included in the National Reimbursement Drug List.

Canopy, Creator of Leading Staff Safety Solution Already Protecting 200,000 U.S. Healthcare Workers, Exits Four Years of Stealth

Retrieved on: 
Wednesday, December 6, 2023
PALO, Violence, Safety, Organization, Wi-Fi, Nursing, Workplace violence, Silicon, Parking, National Healthcare Security Administration, Customer success, Partnership, Growth, Hospital, Workplace, Face, Customer experience, Satellite navigation device, Management, Canopy

PALO ALTO, Calif., Dec. 6, 2023 /PRNewswire/ -- Today, Canopy, the creator of an industry-leading safety solution that helps hospitals protect staff from workplace aggression and violence, emerged from four years of stealth during which its product was exclusively available through distribution partners, white-labeled under their brand names. In a major strategic shift, the company will no longer sell as a white-labeled product, and instead, will sell directly to health systems. With this change, the company is launching Canopy Protect, a new staff safety solution offering health systems the ability to monitor all physical areas of their organization with minimal ongoing maintenance. To make this shift and accelerate its growth, Canopy is hiring aggressively toward its mission to help health systems protect every healthcare worker in America.

Key Points: 
  • Canopy's staff safety solution is an end-to-end service enabling healthcare workers to discreetly signal for help so security and all nearby co-workers can mobilize to provide help within a matter of seconds.
  • Canopy is launching Canopy Protect, a new staff safety offering that enables organizations to protect their workers across all indoor and outdoor locations.
  • Canopy Protect leverages four years of experience building and deploying the leading staff safety solution used by the largest health systems in the country.
  • "Amy is widely recognized as an expert on how technology can be used to address healthcare organizations' staff safety challenges," said Sinha.

Hua Medicine Announces 2023 Interim Results

Retrieved on: 
Friday, August 25, 2023
IGT, DREAM, National Healthcare Security Administration, Rat, Type 2 diabetes, Diabetes, Obesity, Progress, Hong Kong Exchanges and Clearing, Hospital, Patient, NGT, Fructose, American Diabetes Association, ADA, Disease, Pharmacy, Drug discovery, DSM-IV codes, Pancreas, Research, Homeostasis, Kidney, PPG, FKI, Liver, Growth, IND, Fatty liver disease, Endocrinology, DPP-4, Stroke, Chinese University of Hong Kong, MAH, Type 2, Metformin, CUHK, IVD, STA, DKD, Glucokinase, Probability, Metabolism, Liver disease, GK, Nature Communications, SEED, Trial of the century, TIR, Plasma protein binding, GKA, National Healthcare, Physician, AI, Bank, NRDL, Medicine, Congenital hyperinsulinism, Medical device, Pharmaceutical industry, Cryptocurrency, Bayer, T2D

Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2023 (the "Reporting Period").

Key Points: 
  • Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2023 (the "Reporting Period").
  • Dr. Li Chen, the founder and CEO of Hua Medicine, said, "the first half of 2023 was a critical stage for Hua Medicine to begin commercialization.
  • The revenue of Hua Medicine for the first half of 2023 was RMB70.3 million, which was an increase of approximately 299.6% comparing to the second half of 2022.
  • This article contains the statements regarding the future expectations, plans and prospects for Hua Medicine and the investigational product.

Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

Retrieved on: 
Friday, June 30, 2023
Biologics license application, National Healthcare Security Administration, Partnership, Immunoglobulin G, GMG, Myasthenia gravis, Quality of life, Department of Neurology, Xuanwu hospital, Working Group, Euronext, National Healthcare, Patient, MG, Physician, Fudan University, National Medical Products Administration, Acetylcholine receptor, Neonatal Fc receptor, BLA, NMPA, NRDL, Autoimmunity, Safety, Disease, Pharmaceutical industry, Neurology

SHANGHAI, China and CAMBRIDGE, Mass., June 30, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical Products Administration (NMPA) has approved the Biologics License Application (BLA) for VYVGART® (efgartigimod alfa injection), a first-in-class neonatal Fc receptor (FcRn) antagonist, as an add on to standard therapy for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. Zai Lab will now work with the National Healthcare Security Administration (NHSA) for NRDL inclusion to enable broad access for patients.

Key Points: 
  • Zai Lab will now work with the National Healthcare Security Administration (NHSA) for NRDL inclusion to enable broad access for patients.
  • “We are pleased to have the NMPA’s approval for VYVGART for intravenous use.
  • “We appreciate the NMPA for their thorough assessment of VYVGART, recognizing its differentiated profile and the large unmet medical need in China.
  • “We celebrate this achievement with our partner, Zai Lab, who shares our mutual passion to bring needed innovation to people with gMG in China.

argenx and Zai Lab Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

Retrieved on: 
Friday, June 30, 2023
Biologics license application, National Healthcare Security Administration, Partnership, Immunoglobulin G, GMG, Myasthenia gravis, Quality of life, Department of Neurology, Xuanwu hospital, Working Group, Euronext, National Healthcare, Patient, MG, Physician, Fudan University, National Medical Products Administration, Acetylcholine receptor, Neonatal Fc receptor, BLA, NMPA, NRDL, Safety, Disease, Pharmaceutical industry, Neurology

Amsterdam, the Netherlands— June 30, 2023 -- argenx SE (Euronext & Nasdaq: ARGX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has approved the Biologics License Application (BLA) for VYVGART® (efgartigimod alfa injection), a first-in-class neonatal Fc receptor (FcRn) antagonist, as an add on to standard therapy for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. Zai Lab will now work with the National Healthcare Security Administration (NHSA) for NRDL inclusion to enable broad access for patients.

Key Points: 
  • Zai Lab will now work with the National Healthcare Security Administration (NHSA) for NRDL inclusion to enable broad access for patients.
  • ​​​“This approval by the NMPA for VYVGART, our sixth approval globally, is the first-and-only FcRn blocker available for people living with gMG in China.
  • “We celebrate this achievement with our partner, Zai Lab, who shares our mutual passion to bring needed innovation to people with gMG in China.
  • “We appreciate the NMPA for their thorough assessment of VYVGART, recognizing its differentiated profile and the large unmet medical need in China.

Global Health Care Security System Market 2022: Featuring Siemens, Bosch, Honeywell, Cisco, ADT Security & More

Retrieved on: 
Friday, November 4, 2022
Theft, Research, Health care, Awareness, PHI, Unsecured debt, National Healthcare Security Administration, Medicare, Office for Civil Rights, CAGR, Business, Prison on Fire – Life Sentence, Centers for Medicare & Medicaid Services, Asia-Pacific, NITC, Zhenhua Data leak, Center, Civil and political rights, Roger Hawkins (drummer), United States Department of Health and Human Services, HHS, System, Key, Patient, Health, Renewable energy, Pharmaceutical industry

DUBLIN, Nov. 4, 2022 /PRNewswire/ --The "Global Health Care Security System Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 4, 2022 /PRNewswire/ --The "Global Health Care Security System Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global health care security market is projected to grow at a CAGR of 10%.
  • The nature of their business poses unique security challenges that can leave them susceptible to theft & internal misuse.
  • In past few years there is rise in cybercrime & activity breaching the access in health care systems.

Global Health Care Security System Market 2022: Significant Rise in Insider Fraud Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 26, 2022
Technology, General Health, Health, Security, National Healthcare Security Administration, United States Department of Health and Human Services, Business, Health care, Centers for Medicare & Medicaid Services, Unsecured debt, PHI, CAGR, Patient, Theft, HHS, Research, Civil and political rights, Medicare, Zhenhua Data leak, Asia-Pacific, Awareness, Health, System, Office for Civil Rights, NITC, Key, Roger Hawkins (drummer), Prison on Fire – Life Sentence, Center, Renewable energy, Pharmaceutical industry

The "Global Health Care Security System Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Health Care Security System Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global health care security market is projected to grow at a CAGR of 10%.
  • Emerging healthcare technology & innovation are the driving force of the market's growth and therefore, are a key priority prime priority.
  • In past few years there is rise in cybercrime & activity breaching the access in health care systems.

Asimily Ranks No. 170 on the 2022 Inc. 5000 List of Fastest-Growing Private Companies

Retrieved on: 
Wednesday, August 17, 2022
Risk, Anomaly, Industry, National Healthcare Security Administration, GLOBE, Growth, Database, Commonwealth Associates, Inc., Knowledge, Financial Times and McKinsey Business Book of the Year Award, Compliance, Risk management, Inc. (magazine), Industrial internet of things, Inc., Social media, Internet, Completeness, Conference, Globe One Digital, Health care, 3D printing, Medical device, IOT

170 in Inc. Magazines prestigious Inc. 5000 list of the fastest-growing private companies in America.

Key Points: 
  • 170 in Inc. Magazines prestigious Inc. 5000 list of the fastest-growing private companies in America.
  • Asimily has continued to expand our platform to stay on top of the evolving security needs within the healthcare industry.
  • The revenue-growth-based recognition from Inc. Magazine adds to several recent awards Asimily has earned for its security solutions.
  • Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2018 to 2021.

Asimily Announces Seven 2022 Award Wins for Excellence in IoT and Healthcare Device Security

Retrieved on: 
Wednesday, June 8, 2022
Cloud, Risk management, Business intelligence, Leadership, Data analysis, Globe Award, National Healthcare Security Administration, Computer security, Product management, Risk assessment, Health care, Network security, Security, Solution, Intelligence, IOT, ShortList, Silver, GLOBE, Anomaly, Patient, Publication, Internet, Computing, Industry, Gold, Fortification, Information technology, Cloud computing, Medical device, Weapon

The IoT and security awards that Asimily has already earned in 2022 include:

Key Points: 
  • The IoT and security awards that Asimily has already earned in 2022 include:
    Cybersecurity Excellence Awards: IoT Security (gold), Healthcare Security (silver), and Best Cybersecurity Startup (bronze).
  • The 2022 Cybersecurity Excellence Awards honor individuals and companies that demonstrate excellence, innovation, and leadership in information security.
  • Last year, Asimily received the Business Intelligence Groups Stratus Award for Outstanding Achievement in Cloud Computing and IoT, was shortlisted for Computings IoT and Edge Computing Security Award , and took honors for IoT Security at Security Currents CISO Choice Awards .
  • Asimily was also a finalist in the Computing Security Awards , and won IoT Evolution Worlds 2021 IoT Platform Leadership Award and the IoT Evolution Excellence Award .

MedTech Breakthrough Honors Standout Digital Health and Medical Technology Innovation in 2022 MedTech Breakthrough Awards Program

Retrieved on: 
Thursday, May 5, 2022
Online, Cloud, EHR, MDR, Drug development, Digital health, Administration, Cardiology, MHealth, Face, Telehealth, Health information exchange, Solution, Technology, Genomic and Medical Data, Deepak Chopra, Ophthalmology, Dermatology, BrainScope Company, Inc., Honeywell, Program, Medtech, Medical device, National Healthcare Security Administration, Radiology, ECLIPSE, HIE, HC, GRAIL, Orthopedic surgery, Leadership, 3D, Patient engagement in Canada, Global health, Fitness, RICOH, Exercise, LexisNexis Risk Solutions, Schedule, Artificial intelligence, Health, Electronic health record, Pharmaceutical industry, Hospital, Medicine, Health insurance, Risk management, Medical imaging, Health care

LOS ANGELES, May 5, 2022 /PRNewswire-PRWeb/ -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced the winners of the organization's sixth annual awards program, showcasing technologies and companies that drive innovation and exemplify the best in digital health and medical technology solutions across the globe.

Key Points: 
  • LOS ANGELES, May 5, 2022 /PRNewswire-PRWeb/ -- MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced the winners of the organization's sixth annual awards program, showcasing technologies and companies that drive innovation and exemplify the best in digital health and medical technology solutions across the globe.
  • The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Connected Healthcare, Medical Devices, Medical Data and many more.
  • This year's program attracted more than 3,900 nominations from over 15 different countries throughout the world.
  • The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more.